Advertisement
U.S. markets closed

Nanobiotix S.A. (NANO.PA)

Paris - Paris Delayed Price. Currency in EUR
4.4800+0.0620 (+1.40%)
At close: 05:35PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 212.37M
Enterprise Value 195.21M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.31
Price/Book (mrq)61.99
Enterprise Value/Revenue 5.39
Enterprise Value/EBITDA -2.26

Trading Information

Stock Price History

Beta (5Y Monthly) 1.29
52-Week Change 3-25.58%
S&P500 52-Week Change 339.07%
52 Week High 37.9300
52 Week Low 33.8160
50-Day Moving Average 34.5399
200-Day Moving Average 35.4360

Share Statistics

Avg Vol (3 month) 347.26k
Avg Vol (10 day) 328.62k
Shares Outstanding 547.4M
Implied Shares Outstanding 647.4M
Float 822.81M
% Held by Insiders 114.94%
% Held by Institutions 126.52%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -79.31%
Operating Margin (ttm)-253.32%

Management Effectiveness

Return on Assets (ttm)-22.02%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)42.2M
Revenue Per Share (ttm)0.98
Quarterly Revenue Growth (yoy)182.10%
Gross Profit (ttm)N/A
EBITDA -22.3M
Net Income Avi to Common (ttm)-33.47M
Diluted EPS (ttm)-0.7400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)66.33M
Total Cash Per Share (mrq)1.4
Total Debt (mrq)49.17M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.42
Book Value Per Share (mrq)-0.46

Cash Flow Statement

Operating Cash Flow (ttm)-1.04M
Levered Free Cash Flow (ttm)-4.55M